![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
EFFECTIVENESS OF DACLATASVIR PLUS SOFOSBUVIR IN HCV-GT3 PATIENTS RESULTS FROM THE GERMAN HEPATITIS C REGISTRY (DHC-R)
|
|
|
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
S. Mauss1, K. Boeker2, M. Cornberg3, R. Guenther4, H. Klinker5, A. Schober6, K. Weigand7, T. Zimmermann8. T. Nakonz9, C. Fischer10, P. Buggisch11
1Center forHIV andHepatogastroenterology, Duesseldorf; 2Leberpraxis, Hannover; 3Hannover Medical School, Hannover; 4University Hospital Kiel, Kiel; 5University Hospital Wuerzburg, Wuerzburg;6Hepatologische Praxis, Goettingen; 7University Hospital Regensburg, Regensburg; 8Bristol-Myers Squibb GmbH & Co. KGaA, Munich; 9Consultant in Medical AffairsandHEOR, Munich; 10University Hospital Mainz, Mainz; 11IFI Institute forInterdisciplinaryMedicine, Hamburg; all Germany
![HCV1](../images/120116/120116-2/HCV1.gif)
![HCV2](../images/120116/120116-2/HCV2.gif)
![HCV3](../images/120116/120116-2/HCV3.gif)
![HCV4](../images/120116/120116-2/HCV4.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|